Intellipharmaceutics International Inc. (I):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Intellipharmaceutics International Inc. (I) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140544FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Intellipharmaceutics International Inc. (Intellipharmaceutics) is a pharmaceutical company. The company holds expertise in research, development and manufacture of novel and generic targeted-release and controlled-release oral solid dosage drugs. Its product portfolio includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR and Generic Pristiq. Intellipharmaceutics offers products in the areas of neurology, gastrointestinal tract, cardiovascular, diabetes and pain. The company’s technology portfolio includes IntelliFoam, IntelliGITransporter, IntelliMatrix, IntelliOsmotics, IntelliPaste, IntelliShuttle, and IntelliPellets among others. It has partnership with Par Pharmaceutical, Inc. The company was formerly known as Intellipharmaceutics Ltd. Intellipharmaceutics is headquartered in Toronto, Ontario, Canada.

Intellipharmaceutics International Inc. Key Recent Developments

Dec 02, 2013: Intellipharmaceutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
Nov 27, 2013: Intellipharmaceutics announces at-the-market offering of common shares
Oct 01, 2013: Intellipharmaceutics Announces Third Quarter 2013 Results
Jul 02, 2013: Intellipharmaceutics Announces Second Quarter 2013 Results
Apr 24, 2013: Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare Conference

This comprehensive SWOT profile of Intellipharmaceutics International Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intellipharmaceutics International Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Intellipharmaceutics International Inc. – Key Information
Intellipharmaceutics International Inc. – Overview
Intellipharmaceutics International Inc. – Key Employees
Intellipharmaceutics International Inc. – Key Employee Biographies
Intellipharmaceutics International Inc. – Key Operational Heads
Intellipharmaceutics International Inc. – Major Products and Services
Intellipharmaceutics International Inc. – History
Intellipharmaceutics International Inc. – Company Statement
Intellipharmaceutics International Inc. – Locations And Subsidiaries
Intellipharmaceutics International Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Intellipharmaceutics International Inc. – Business Description
Intellipharmaceutics International Inc. – Corporate Strategy
Intellipharmaceutics International Inc. – SWOT Analysis
SWOT Analysis – Overview
Intellipharmaceutics International Inc. – Strengths
Intellipharmaceutics International Inc. – Weaknesses
Intellipharmaceutics International Inc. – Opportunities
Intellipharmaceutics International Inc. – Threats
Intellipharmaceutics International Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Intellipharmaceutics International Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intellipharmaceutics International Inc., Key Information
Intellipharmaceutics International Inc., Key Ratios
Intellipharmaceutics International Inc., Share Data
Intellipharmaceutics International Inc., Major Products and Services
Intellipharmaceutics International Inc., History
Intellipharmaceutics International Inc., Key Employees
Intellipharmaceutics International Inc., Key Employee Biographies
Intellipharmaceutics International Inc., Key Operational Heads
Intellipharmaceutics International Inc., Other Locations
Intellipharmaceutics International Inc., Subsidiaries
Intellipharmaceutics International Inc., Key Manufacturing facilities
Intellipharmaceutics International Inc., Key Competitors
Intellipharmaceutics International Inc., SWOT Analysis
Intellipharmaceutics International Inc., Ratios based on current share price
Intellipharmaceutics International Inc., Annual Ratios
Intellipharmaceutics International Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Intellipharmaceutics International Inc., Performance Chart
Intellipharmaceutics International Inc., Ratio Charts

★海外企業調査レポート[Intellipharmaceutics International Inc. (I):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Citrix Systems, Inc.:企業のM&A・提携・投資分析
    Citrix Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Citrix Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Caterpillar Inc. (CAT):企業のM&A・提携動向(発電分野)
    Summary Caterpillar Inc. (Caterpillar) is a manufacturer of construction and mining equipment, diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. The company designs, manufactures, markets, and sells construction, mining, and forestry machinery, engines and rela …
  • Usha Martin Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Usha Martin Limited Mergers and …
  • Banque Pictet and Cie SA:企業の戦略・SWOT・財務分析
    SummaryBanque Pictet and Cie SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Lupatech S.A. (LUPA3):企業の財務及び戦略的SWOT分析
    Summary Lupatech S.A. (Lupatech) is a service provider for oil and gas companies that supplies products and services for the oil and gas sector. The company offers products such as polyster ropes, oil and gas valves, special pipe lining, gas compressors, fiber optic monitoring systems, and others. L …
  • Jenson & Nicholson (India) Ltd (JENSONICOL):企業の財務及び戦略的SWOT分析
    Summary Jenson & Nicholson (India) Ltd (J&N) is a chemical company that manufactures paint and its products. The company manufactures and markets sectors of paint and varnishes. Its key products include designer finish, emulsions, distemper, enamels, texture paint, cement paint, enamels, wood coatin …
  • Petrol d.d., Ljubljana (PETG):企業のM&A・提携動向(エネルギー分野)
    Summary Petrol d.d., Ljubljana (Petrol) is an oil and gas supplier. The company supplies oil and other energy products to the Slovenian market. It provides automotive goods and services and a wide selection of household and food products and other merchandise. Petrol provides products such as energy …
  • Perfint Healthcare Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Perfint Healthcare Pvt Ltd (Perfint), formerly Perfint Engineering Services Pvt Ltd is a medical device company that develops image guided interventional products on onchology and pain care. The company’s products comprise MAXIO, stereotactic accessory to a Computed Tomography system; ROBIO …
  • Imperial Holdings, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Imperial Holdings, Ltd. Mergers …
  • Dynavax Technologies Corporation (DVAX)(製薬・医療分野):企業M&A動向
    Summary Dynavax Technologies Corporation (Dynavax Technologies), formerly known as Double Helix Corporation is a clinical-stage biopharmaceutical company. It is involved in the discovery and development of products used for the treatment of infectious and inflammatory diseases. The company's product …
  • PDL BioPharma Inc (PDLI)-製薬・医療分野:企業M&A・提携分析
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Proteome Sciences Plc (PRM):企業のM&A・提携動向(医療機器分野)
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine in various areas such as biomarker assays, isobaric and isotopic reagents, biomarker services and proprietary biomarkers. The company specializes in providing proteomics and p …
  • Scancell Holdings Plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Scancell Holdings Plc Mergers a …
  • Kilitch Drugs India Ltd (KILITCH)-製薬・医療分野:企業M&A・提携分析
    Summary Kilitch Drugs India Ltd (Kilitch) is a pharmaceutical company that manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. The company offers products such as carbapenems, cephalosporins, beta-lactam antibiotics, steroids and hormones, gastrology and …
  • United Food Holdings Limited:戦略・SWOT・企業財務分析
    United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Abera Bioscience AB:製品開発パイプライン動向2015
    Abera Bioscience AB - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Abera Bioscience AB - Product Pipeline Review - 2015’, provides an overview of the Abera Bioscience AB’s pharmaceutical research and development focus. This report provides comprehensive information on the current …
  • Orchid Orthopedic Solutions LLC-医療機器分野:企業M&A・提携分析
    Summary Orchid Orthopedic Solutions LLC (Orchid Orthopedic) is a medical device company that offers orthopedic and medical device contract design, and manufacturing outsourcing services. The company provides proprietary solutions such as medical device design and development, implant bone in-growth …
  • Zenrin Co., Ltd. (9474):企業の財務及び戦略的SWOT分析
    Summary Zenrin Co., Ltd. (Zenrin) is an information technology company that provides premium mapping services and products. It is a provider of map software, in-car navigation software and related IT services for various purposes. Zenrin's products include residential maps, digital maps, special pur …
  • Medison Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Medison Co., Ltd. Mergers and A …
  • RWE Npower Holdings plc-エネルギー分野:企業M&A・提携分析
    Summary RWE Npower Holdings plc (RWE Npower), a subsidiary of RWE AG, is an energy utility that generates and supplies electricity and distributes gas in the UK. Through its subsidiaries, RWE Npower Group plc and RWE Generation UK plc, the company conducts electricity supply and generation respectiv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆